semaglutide patent canada Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent As patents on weight-loss drugs

While the parent trials primary outcomes were changes in adipose tissue volume (measured by CT) and body composition (DXA scans) at 32 weeks, our current analysis focuses on epigenetic aging markers as secondary/exploratory outcomes

Nelson AJ, OBrien EC, Kaltenbach LA, et al

They can affect the bladder, kidneys, or other parts of the urinary system

The literature is conflicting on this topic, and although in vitro studies in obese mice have shown a positive effect of semaglutide in promoting muscle protein synthesis, increasing the relative proportion of skeletal muscle, and improving muscle function [119, 120], a synergistic dietary strategy such as the MD may help mitigate this concern and optimise the quality of weight loss

Davies, Melanie